<DOC>
	<DOCNO>NCT02606630</DOCNO>
	<brief_summary>This open-label positron emission tomography ( PET ) study design determine effect ABT-555 translocator protein expression level participant relapse form multiple sclerosis .</brief_summary>
	<brief_title>11C-PBR28 Positron Emission Tomography Study Evaluate Effect ABT 555 Subjects With Relapsing Forms Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Diagnosis relapsingremitting MS ( RRMS ) relapse secondary progressive MS ( SPMS ) Neurologically stable Screening , investigator 's judgment actively experience recover recent relapse 30 day precede Screening Visit A Kurtzke Expanded Disability Status Scale ( EDSS ) score 1.0 6.0 , inclusive Screening Visit High mixed affinity binder TSPO , determine rs6971 polymorphism genotyping screen Diagnosis primary progressive nonrelapsing secondary progressive MS Smoking 10 cigarette per day use nicotine patch Known history , positive screen test result hepatitis C virus hepatitis B virus Varicella herpes zoster virus infection severe viral infection within 6 week Screening Any type live virus vaccine 4 week randomization History abnormal laboratory result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Relapsing multiple sclerosis</keyword>
</DOC>